Arezou A. Ghazani

7.8k total citations · 2 hit papers
30 papers, 5.0k citations indexed

About

Arezou A. Ghazani is a scholar working on Molecular Biology, Genetics and Cancer Research. According to data from OpenAlex, Arezou A. Ghazani has authored 30 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 11 papers in Genetics and 11 papers in Cancer Research. Recurrent topics in Arezou A. Ghazani's work include Cancer Genomics and Diagnostics (10 papers), Genetic factors in colorectal cancer (7 papers) and BRCA gene mutations in cancer (4 papers). Arezou A. Ghazani is often cited by papers focused on Cancer Genomics and Diagnostics (10 papers), Genetic factors in colorectal cancer (7 papers) and BRCA gene mutations in cancer (4 papers). Arezou A. Ghazani collaborates with scholars based in United States, Canada and Croatia. Arezou A. Ghazani's co-authors include Warren C. W. Chan, Devika B. Chithrani, Tanya S. Hauck, Hakho Lee, Ralph Weissleder, Cesar M. Castro, David Issadore, Jaehoon Chung, Huilin Shao and Monty Liong and has published in prestigious journals such as SHILAP Revista de lepidopterología, Nano Letters and Small.

In The Last Decade

Arezou A. Ghazani

26 papers receiving 4.9k citations

Hit Papers

Determining the Size and Shape Dependence of Gold Nanopar... 2006 2026 2012 2019 2006 2007 1000 2.0k 3.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Determining the Size and Shape Dependence of Gold Nanoparticle Uptake into Mammalian Cells
    2006 3.9k citations Arezou A. Ghazani, Warren C. W. Chan et al. profile →
  2. Assessing the Effect of Surface Chemistry on Gold Nanorod Uptake, Toxicity, and Gene Expression in Mammalian Cells
    2007 581 citations Tanya S. Hauck, Arezou A. Ghazani et al. Small profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Arezou A. Ghazani United States 11 2.1k 2.0k 2.0k 1.5k 1.4k 30 5.0k
Shuaidong Huo China 32 2.8k 1.3× 2.2k 1.1× 2.0k 1.0× 2.0k 1.3× 768 0.6× 69 5.7k
Bo Pang China 14 1.9k 0.9× 1.2k 0.6× 1.5k 0.8× 1.0k 0.7× 736 0.5× 19 3.6k
Alexandre Albanese Canada 16 2.1k 1.0× 1.5k 0.8× 2.0k 1.0× 1.4k 0.9× 579 0.4× 28 5.0k
Carl Walkey Canada 12 2.4k 1.2× 2.0k 1.0× 3.3k 1.7× 2.0k 1.3× 889 0.7× 19 6.0k
Beatriz Pelaz Spain 37 2.8k 1.3× 2.7k 1.4× 2.3k 1.2× 1.8k 1.1× 1.4k 1.0× 102 6.2k
Geoffrey von Maltzahn United States 22 3.0k 1.4× 2.2k 1.1× 2.1k 1.1× 1.8k 1.2× 1.1k 0.8× 30 5.7k
Shubin Jin China 27 2.5k 1.2× 1.9k 1.0× 2.2k 1.1× 1.8k 1.1× 579 0.4× 47 5.3k
Xinglu Huang China 41 3.0k 1.4× 2.8k 1.4× 2.2k 1.1× 2.2k 1.4× 511 0.4× 84 6.5k
Daniel F. Moyano United States 32 1.8k 0.9× 1.8k 0.9× 1.8k 0.9× 1.8k 1.2× 874 0.6× 53 5.0k
Xianghong Peng United States 24 1.9k 0.9× 1.0k 0.5× 1.1k 0.6× 1.8k 1.2× 1.5k 1.1× 45 4.3k

Countries citing papers authored by Arezou A. Ghazani

Since Specialization
Citations

This map shows the geographic impact of Arezou A. Ghazani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arezou A. Ghazani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arezou A. Ghazani more than expected).

Fields of papers citing papers by Arezou A. Ghazani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arezou A. Ghazani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arezou A. Ghazani. The network helps show where Arezou A. Ghazani may publish in the future.

Co-authorship network of co-authors of Arezou A. Ghazani

This figure shows the co-authorship network connecting the top 25 collaborators of Arezou A. Ghazani. A scholar is included among the top collaborators of Arezou A. Ghazani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arezou A. Ghazani. Arezou A. Ghazani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ćuk, Mario, et al.. (2024). Novel RAI1:c.2736delC Variant in Smith–Magenis Syndrome: Identification by Whole Genome Sequencing and Joint Analysis. Journal of Personalized Medicine. 14(9). 901–901. 1 indexed citations
2.
Schwartz, Alison, et al.. (2024). Germline and Somatic Fumarate Hydratase Testing in Atypical Uterine Leiomyomata. Cancer Prevention Research. 17(5). 201–208. 1 indexed citations
3.
4.
Ağaoğlu, Nihat Buğra, et al.. (2024). Genomic disparity impacts variant classification of cancer susceptibility genes in Turkish breast cancer patients. Cancer Medicine. 13(3). e6852–e6852. 5 indexed citations
5.
6.
Rana, Huma Q., Anu Chittenden, Raymond A. Isidro, et al.. (2024). Advancing Precision Oncology in Hereditary Paraganglioma-Pheochromocytoma Syndromes: Integrated Interpretation and Data Sharing of the Germline and Tumor Genomes. Cancers. 16(5). 947–947. 1 indexed citations
7.
Isidro, Raymond A., Anu Chittenden, Alison Schwartz, et al.. (2024). Development and evaluation of INT2GRATE: a platform for comprehensive assessment of the role of germline variants informed by tumor signature profile in Lynch syndrome. Frontiers in Oncology. 13. 1284690–1284690. 1 indexed citations
8.
9.
Schwartz, Alison, Huma Q. Rana, Vanesa Rojas‐Rudilla, et al.. (2022). Vulvar Melanoma in association with germline MITF p.E318K variant. Cancer Genetics. 262-263. 102–106. 2 indexed citations
10.
Ağaoğlu, Nihat Buğra, Özden Hatırnaz Ng, Özlem Akgün Doğan, et al.. (2022). Concurrent Pathogenic Variants of BRCA1, MUTYH and CHEK2 in a Hereditary Cancer Family. Cancer Genetics. 268-269. 128–136. 2 indexed citations
11.
Schwartz, Alison, Danielle K. Manning, Anu Chittenden, et al.. (2022). An integrated somatic and germline approach to aid interpretation of germline variants of uncertain significance in cancer susceptibility genes. Frontiers in Oncology. 12. 942741–942741. 6 indexed citations
12.
13.
Rana, Huma Q., Alison Schwartz, Danielle K. Manning, et al.. (2021). Pathogenicity of VHL variants in families with non-syndromic von Hippel-Lindau phenotypes: An integrated evaluation of germline and somatic genomic results. European Journal of Medical Genetics. 64(12). 104359–104359. 8 indexed citations
14.
Gee, Michael S., Arezou A. Ghazani, Rizwan Haq, et al.. (2016). Point of care assessment of melanoma tumor signaling and metastatic burden from μNMR analysis of tumor fine needle aspirates and peripheral blood. Nanomedicine Nanotechnology Biology and Medicine. 13(3). 821–828. 7 indexed citations
15.
Ghazani, Arezou A., Shaunagh McDermott, Melina Pectasides, et al.. (2013). Comparison of select cancer biomarkers in human circulating and bulk tumor cells using magnetic nanoparticles and a miniaturized micro-NMR system. Nanomedicine Nanotechnology Biology and Medicine. 9(7). 1009–1017. 29 indexed citations
16.
Ghazani, Arezou A., Melina Pectasides, Amita Sharma, et al.. (2013). Molecular characterization of scant lung tumor cells using iron-oxide nanoparticles and micro-nuclear magnetic resonance. Nanomedicine Nanotechnology Biology and Medicine. 10(3). 661–668. 32 indexed citations
17.
Issadore, David, Jaehoon Chung, Huilin Shao, et al.. (2012). Ultrasensitive Clinical Enumeration of Rare Cells ex Vivo Using a Micro-Hall Detector. Science Translational Medicine. 4(141). 141ra92–141ra92. 191 indexed citations
18.
Ghazani, Arezou A., Cesar M. Castro, Rostic Gorbatov, Hakho Lee, & Ralph Weissleder. (2012). Sensitive and Direct Detection of Circulating Tumor Cells by Multimarker µ-Nuclear Magnetic Resonance. Neoplasia. 14(5). 388–IN2. 48 indexed citations
19.
Hauck, Tanya S., Arezou A. Ghazani, & Warren C. W. Chan. (2007). Assessing the Effect of Surface Chemistry on Gold Nanorod Uptake, Toxicity, and Gene Expression in Mammalian Cells. Small. 4(1). 153–159. 581 indexed citations breakdown →
20.
Ghazani, Arezou A., et al.. (2006). Cellular Imaging and Surface Marker Labeling of Hematopoietic Cells Using Quantum Dot Bioconjugates. PubMed. 12(2). 94–98. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shuaidong Huo Breakdown of academic impact, for papers by Bo Pang Breakdown of academic impact, for papers by Alexandre Albanese Breakdown of academic impact, for papers by Carl Walkey Breakdown of academic impact, for papers by Beatriz Pelaz Breakdown of academic impact, for papers by Geoffrey von Maltzahn Breakdown of academic impact, for papers by Shubin Jin Breakdown of academic impact, for papers by Xinglu Huang Breakdown of academic impact, for papers by Daniel F. Moyano Breakdown of academic impact, for papers by Xianghong Peng
Rankless by CCL
2026